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pon completion of mitosis, daughter nuclei assemble
all of the organelles necessary for the implemen-
tation of nuclear functions. We found that upon
entry into daughter nuclei, snRNPs and SR proteins do not
immediately colocalize in nuclear speckles. SR proteins
accumulated in patches around active nucleolar organizing
regions (NORs) that we refer to as NOR-associated patches
(NAPs), whereas snRNPs were enriched at other nuclear
regions. NAPs formed transiently, persisting for 15–20
min before dissipating as nuclear speckles began to form
U
 
in G1. In the absence of RNA polymerase II transcription,
NAPs increased in size and persisted for at least 2 h, with
delayed localization of SR proteins to nuclear speckles. In
addition, SR proteins in NAPs are hypophosphorylated,
and the SR protein kinase Clk/STY colocalizes with SR
proteins in NAPs, suggesting that phosphorylation releases
SR proteins from NAPs and their initial target is transcription
sites. This work demonstrates a previously unrecognized
role of NAPs in splicing factor trafficking and nuclear
speckle biogenesis.
 
Introduction
 
At the onset of mitosis, mammalian cell nuclei undergo dra-
matic structural and functional alterations such as chromatin
condensation, inactivation of the transcription machinery,
nuclear envelope breakdown, and disassembly of nuclear com-
partments such as nucleoli and interchromatin granule clusters
(IGCs). The constituents of nuclear compartments become
diffusely distributed throughout the cytosol, and some of them
assemble into various cytoplasmic structures as mitosis progresses
(Ferriera et al., 1994; Jimenez-Garcia et al., 1994; Thiry, 1995;
Dundr et al., 1997; Dundr and Olson, 1998; Everett et al.,
1999). Although the function of the cytoplasmic bodies is
largely unknown, the segregation of components from distinct
nuclear compartments into distinct cytoplasmic bodies sug-
gests that they maintain multiprotein complexes for the various
nuclear bodies throughout mitosis (for review see Hernandez-
Verdun et al., 2002). The nuclear entry of many nuclear body
constituents is likely to occur by active transport of single mac-
romolecules or macromolecular complexes, not by direct uptake
or fusion of the entire cytoplasmic structures with forming
nuclei. Organization of the nuclear compartments begins at
mitotic exit. Interestingly, assembly of the nuclear envelope
is followed in telophase by sequential nuclear entry of RNA
polymerase II and transcription factors, followed by entry of
pre-mRNA splicing factors and other pre-mRNA processing
factors (Prasanth et al., 2003).
As cells enter G1, chromatin decondenses, the nuclei
expand, global transcription is reactivated, and functional
nuclear compartments such as the nucleoli, Cajal bodies
(CBs), PML bodies, and nuclear speckles are reestablished.
Little is known about nuclear body reformation aside from the
nucleolus, for which a multistep process is initiated by rRNA
transcription at nucleolar organizing regions (NORs) and is
followed by recruitment of rRNA-processing factors and other
nucleolar proteins. The nucleolar protein fibrillarin coats the
surfaces of chromosomes during mitosis, and then decorates
NORs when they become transcriptionally active and is involved
in early rRNA processing events (for review see Hernandez-
Verdun et al., 2002). Nucleolar proteins that are involved in
late rRNA processing, such as nucleolin, remain cytosolic dur-
ing mitosis, and then enter daughter nuclei and form structures
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called prenucleolar bodies or nucleolar-derived foci before
recruitment to nucleoli (for reviews see Dundr et al., 1997;
Dundr and Olson, 1998; Sleeman and Lamond, 1999; Hernan-
dez-Verdun et al., 2002).
IGCs, also called nuclear speckles, are storage, assem-
bly, and/or modification sites for pre-mRNA processing fac-
tors in interphase nuclei (for review see Lamond and Spector,
2003). Nuclear speckles disassemble during mitosis, and their
constituents are diffusely distributed throughout the cyto-
plasm, later organizing into cytoplasmic structures called mi-
totic IGCs (MIGs; Verheijen et al., 1986; Leser et al., 1989;
Ferriera et al., 1994). Early studies on the behavior of nuclear
speckles through the cell cycle described MIGs as the mitotic
equivalent of interphase nuclear speckles based on their simi-
lar granular structure and composition (Spector and Smith,
1986; Leser et al., 1989; Thiry, 1995; see Fig. 1, a–c). MIGs
disappear concomitant with nuclear entry of pre-mRNA pro-
cessing factors at telophase (Ferriera et al., 1994; Prasanth et
al., 2003), and then nuclear speckles reassemble in G1 and are
maintained through interphase.
To understand in more detail how the nuclear speckle
pattern is established in daughter nuclei, we studied the lo-
calization and dynamics of nuclear speckle constituents at
mitotic exit. Here, we show that in telophase splicing factors
do not immediately localize to nuclear speckles upon nu-
clear entry. Surprisingly, different families of splicing fac-
tors initially target different subnuclear regions. In telo-
phase, SR splicing factors initially localize around NORs
before the establishment of nuclear speckles, whereas sn-
RNPs localize in polar regions of daughter nuclei. We pro-
pose that the concentration of SR proteins in a region of the
nucleus away from other splicing factors could increase the
likelihood for arginine-serine rich (RS) domain–RS domain
interactions, thus facilitating the intermolecular associations
important for subsequent association with transcription sites
and nuclear speckles.
Figure 1. Distribution of SR splicing factors
during telophase. Endogenous SR splicing factor
SF2/ASF (green) and DNA (pseudocolored
red) localization during the HeLa cell cycle (a–e).
Throughout mitosis, nuclear speckle constitu-
ents reside in the cytosol and in MIGs (a–c,
arrowheads). At telophase, SF2/ASF enters
daughter nuclei and localizes in NAPs (d,
arrows) that correspond to DAPI-negative
zones (d, inset, arrows) before it is localized
in nuclear speckles in G1 (e). YFP-SF2/ASF
localization was followed by confocal micros-
copy during telophase in living cells (f–k),
where it initially accumulates in NAPs (f–j,
arrows) and later localizes to nuclear speckles
(k, arrowheads; see Video 1 for the entire time
course, available at http://www.jcb.org/cgi/
content/full/jcb.200404120/DC1). Images
in f–k are 2-m optical sections. Projections of
deconvolved z-stacks (l–o) show that SR splic-
ing factor SC35-CFP (l, arrow, pseudocolored
green) colocalizes in NAPs with SF2/ASF
(m and n, arrows). The SR protein kinase Clk/
STY (q, arrow) colocalizes with endogenous
SF2/ASF in NAPs (p and r, arrows). DNA
was stained with DAPI to monitor cell cycle
phase (a–e, o, and s; arrows in o and s indi-
cate NAP position). Bars, 5 m.
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Results
 
SR proteins accumulate in NOR-
associated patches (NAPs) upon 
entering telophase nuclei
 
Splicing factors reside in the cytosol during mitosis and assem-
ble into MIGs as mitosis progresses (Fig. 1, a–c). MIGs begin
to appear during metaphase, when two or three MIGs form near
the periphery of the metaphase plate (Fig. 1 a, arrowheads; Fer-
riera et al., 1994). During anaphase, additional MIGs form
(Fig. 1 b, arrowheads), increasing in number and size until telo-
phase (Fig. 1 c, arrowheads; Ferriera et al., 1994), when splic-
ing factors are imported into daughter nuclei resulting in the
formation of nuclear speckles in G1 (Fig. 1 e; Prasanth et al.,
2003). To our surprise, we observed a novel nuclear localiza-
tion of the SR splicing factor SF2/ASF at the earliest time point
of SF2/ASF nuclear entry. In telophase, several bright patches
(NAPs) of SF2/ASF were found inside daughter nuclei (Fig. 1
d, arrows). There was a reduction of DAPI staining (Fig. 1 d,
inset) and histone H2B localization (not depicted) in these re-
gions, suggesting that DNA is decondensed or absent in the ar-
eas where NAPs form.
To study the nuclear entry of SF2/ASF in living daugh-
ter nuclei with regard to NAPs, we generated a HeLa cell
line stably expressing YFP-SF2/ASF. During telophase,
YFP-SF2/ASF transiently accumulated in NAPs that in-
creased in size over 15 min (Fig. 1, f–i) and then began to
disappear after 
 

 
20 min (Fig. 1, i and j) as the cells entered
G1 and nuclear speckles formed (Fig. 1 k, arrowheads). The
complete time-lapse video of this sequence is available on-
line (Video 1, available at http://www.jcb.org/cgi/content/
full/jcb.200404120/DC1). Repeated analysis of YFP-SF2/
ASF localization in NAPs in living cells showed that accu-
mulation in NAPs was transient, and it typically persisted for
15–20 min in HeLa telophase cells before NAPs disappeared
and speckles formed (Fig. S1, a–d; and Video 2, available at
http://www.jcb.org/cgi/content/full/jcb.200404120/DC1). In
cases when NAP formation was staggered by several min-
utes between two daughter nuclei (e.g., compare the timing
of NAP assembly/disassembly between the two daughter nu-
clei in Fig. 1, f–j), NAP formation and dissipation was al-
ways coordinated among multiple NAPs within the same
daughter nucleus, and again NAPs remained intact for 
 

 
15–
20 min in each nucleus.
Figure 2. SR proteins in NAPs are hypophosphorylated. SC35 anti-
body (b, arrow), which recognizes hyperphosphorylated SC35, does
not recognize the SC35 in NAPs (a, arrow) and is absent from the
nucleus (c and d, arrows). 3C5 antibody that recognizes a family of
hyperphosphorylated SR proteins (f, arrow) also does not recognize SR
proteins in NAPs (e, arrow) and is absent from the nucleus (g and h,
arrows). Projections of deconvolved image stacks illustrate the strictly
cytoplasmic localization of hyperphosphorylated SR proteins as well as
exclusion from nuclei (a–h). SCf11 (j, arrows) colocalizes with YFP-
SF2/ASF in NAPs (i and k, arrows) and recognizes SC35 by immuno-
blot only when cell extract is treated with phosphatase (m, lane 2).
Arrows in d, h, and l indicate NAP position. Bar, 5 m.
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Next, we were interested in determining if additional SR
proteins localize in NAPs during telophase. We found that the
SR splicing factor SC35 tagged with CFP (Fig. 1 l, arrows)
colocalized with SF2/ASF in NAPs (Fig. 1 m, arrows). Addi-
tionally, some endogenous SR protein kinase Clk/STY (Fig. 1
q, arrows) that regulates associations among SR proteins (Col-
will et al., 1996b) colocalized with endogenous SF2/ASF in
NAPs (Fig. 1 p, arrows). The presence of Clk/STY in NAPs
suggests that modulation of SR protein phosphorylation could
play a role in SR protein complex assembly and/or release of
SR proteins from NAPs, which is similar to the role Clk/STY
plays in releasing SR proteins from interphase speckles (Col-
will et al., 1996a,b; Sacco-Bubulya and Spector, 2002).
Immunolocalization studies allowed us to determine the
phosphorylation state of SR proteins in NAPs. An antibody that
recognizes the phosphorylated form of SC35 (Fu and Maniatis,
1990) labeled cytoplasmic MIGs and did not recognize any nu-
clear SC35 during telophase (Fig. 2 b). This antibody does not
recognize SC35 in NAPs (Fig. 2 b, arrow), which is consistent
with the possibility that the SC35 in NAPs must be in a hypo-
phosphorylated state (Prasanth et al., 2003). In fact, hyperphos-
phorylated SR proteins in general are not found in NAPs, as an-
tibodies 3C5 (Fig. 2 f, arrow; Turner and Franchi, 1987) and
mAb104 (Roth et al., 1990), which recognize phosphoepitopes
on a subset of SR proteins, also did not label NAPs or recognize
nuclear SR proteins until G1. However, antibody SCf11 that
preferentially recognizes hypophosphorylated SC35 (Fig. 2 j,
arrows; Cavaloc et al., 1999) colocalized with YFP-SF2/ASF in
NAPs (Fig. 2 i, arrows). An immunoblot of HeLa extract con-
firmed that SCf11 recognizes SC35 only in cell extract treated
with phosphatase (Fig. 2 m, lane 2), preferentially recognizing
hypophosphorylated SC35. Therefore, SR proteins in NAPs are
predominantly hypophosphorylated, a characteristic that would
promote SR protein–SR protein association in NAPs.
 
snRNPs are not enriched at NAPs
 
We expected that all nuclear speckle components would simul-
taneously reassemble into nuclear speckles upon entry into
daughter nuclei, and we initially suspected that NAPs represent
the first nuclear speckles in daughter nuclei. However, although
SR proteins and snRNPs colocalize in interphase speckles
(Huang and Spector, 1992) and in MIGs (Ferriera et al., 1994),
NAPs are not enriched in snRNPs as shown by using an anti-
body against the U2 snRNP protein B
 

 
 (Fig. 3, compare arrows
in a and b). Interestingly, the majority of B
 

 
 accumulated in re-
gions of telophase daughter nuclei (Fig. 3 b, arrowheads) dis-
tinct from NAPs. DAPI staining indicates that DNA is decon-
densed or absent in these regions (Fig. 3 d, arrowheads). In
addition, an antibody that recognizes the 5
 

 
 m
 
3
 
G cap of the
snRNAs also showed snRNA accumulation in regions of telo-
phase daughter nuclei distinct from NAPs (unpublished data).
Because snRNP maturation is thought to occur in CBs (Sleeman
and Lamond, 1999), we examined the localization of the CB
protein p80 coilin in telophase cells. Coilin was found in regions
of telophase nuclei (Fig. 3 f, arrowheads), distinct from NAPs
(Fig. 3 e, arrows). In fact, coilin and U2 snRNP protein B
 

 
 were
colocalized in telophase nuclei (Fig. 3, j, k, and m, arrowheads)
in areas separate from NAPs (Fig. 3, i–n, arrows). The colocal-
Figure 3. snRNPs and coilin are not enriched
in NAPs. snRNPs (b, arrowheads) are enriched
in regions of daughter nuclei away from SF2/
ASF NAPs (a, arrows). Coilin is also found in
regions of daughter nuclei (f, arrowheads;
5P10 antibody), away from SF2/ASF NAPs
(e, arrow). The U2snRNP protein B (j, arrow-
heads) colocalized with coilin (k, arrowheads;
R228 antibody; merge shown in m, arrow-
heads) in regions separate from NAPs, which
are indicated by arrows (i–n). The two regions
are clearly distinct in a merged image of YFP-
SF2/ASF and B (l). DNA was stained with
DAPI (d, h, and n). Arrows indicate NAP posi-
tion (a–n). Arrowheads indicate “polar” local-
ization of U2-B (b–d), coilin (f–h), or both
U2-B and coilin (j–n). DNA was stained with
DAPI (d, h, and n). Bars, 5 m.
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ization of snRNPs and coilin suggests that in addition to NAPs
there are regions of daughter nuclei that could be initial sites for
snRNP assembly and/or modification (see Discussion).
 
NAPs surround transcriptionally active 
NORs
 
Because NORs are activated in mitosis, we were interested to
determine if there is a relationship between NORs and NAPs.
Immunofluorescence analysis verified that SR proteins ini-
tially surround NORs upon nuclear entry. Endogenous SF2/
ASF was localized around foci of fibrillarin in telophase
daughter nuclei in HeLa cells (Fig. 4, a–c, arrows), in non-
transformed human fibroblast IMR90 cells (Fig. 4, d–g, ar-
rows), and in human osteosarcoma U2OS cells (Fig. 4, h–k,
arrows). Some SF2/ASF is still present in MIGs at this stage
(Fig. 4, a, d, and h, arrowheads). As there are multiple NORs
in each nucleus (see Discussion), multiple NAPs were seen in
these cell lines in telophase (Fig. 4, a, d, and h). To determine
if the NORs are transcriptionally active when NAPs are
formed, we looked for evidence of RNA polymerase I activity
Figure 4. NAPs surround transcriptionally active NORs during telophase. During telophase, endogenous SF2/ASF localizes in NAPs (a, arrow) surrounding
foci of fibrillarin (b, arrow) in HeLa cells. Endogenous SF2/ASF (d, arrow) is localized in NAPs surrounding foci of fibrillarin (e, arrow) in the nontrans-
formed cell line IMR90. Endogenous SF2/ASF (h, arrow) is localized in NAPs surrounding foci of fibrillarin (i, arrow) in U2OS cells. SF2/ASF is also in
MIGs at this stage (a–k, arrowheads). Endogenous SF2/ASF (l, arrow) surrounds foci of the RNA pol I transcription factor upstream binding factor (m, arrow)
in HeLa cells. RNA-FISH for ribosomal RNA (q, arrows) showed that SF2/ASF NAPs (p, arrows) surrounded transcriptionally active NORs. RNA-FISH using
oligo dT probes demonstrated that polyadenylated RNA (u, arrows) was absent from SF2/ASF NAPs (t, arrows). DNA was stained with DAPI (g, k, o, s,
and w). NAP position is indicated by arrows (a–w). Bars, 5 m.
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in the NORs. Foci of the RNA polymerase I transcription fac-
tor upstream binding factor (Fig. 4 m, arrow) that is localized
in transcriptionally active NORs (Jordan et al., 1996; Roussel
et al., 1996), foci of nascent transcripts (presumably RNA
polymerase I transcripts; Fig. S1, i and j), and pre-ribosomal
RNAs detected by RNA-FISH (Fig. 4 q, arrows) were sur-
rounded by NAPs (Fig. 4 p, arrows).
SR splicing factors colocalize with pre-mRNAs in inter-
phase nuclei (Misteli et al., 1997, 1998; Misteli and Spector,
1999; Shopland et al., 2003); therefore, it was important to rule
out the possibility that SR protein accumulation in NAPs is a
result of RNA polymerase II transcription or pre-mRNA pro-
cessing in these regions. RNA-FISH using an oligo-dT probe
showed that polyA
 

 
 RNA is not present in NAPs (Fig. 4 u, ar-
rows) or elsewhere in the daughter nuclei. In addition, NAPs
did not contain nascent transcripts labeled by incorporation of
5-fluoro-UTP (Fig. S1, i and j). Finally, we ruled out the possi-
bility that NAPs correspond to other nucleolar-associated nu-
clear bodies that could be in the early stages of assembly dur-
ing telophase. Proteins such as nucleolin (not depicted) and
fibrillarin (Fig. 4) were not present in NAPs, ruling out the pos-
sibility that these are prenucleolar bodies (Ochs et al., 1985;
Hernandez-Verdun et al., 2002). NAPs also do not represent
initial assembly sites for the perinucleolar compartment (PNC),
a transcriptionally active domain that contains pre-mRNA pro-
cessing factors (Matera et al., 1995; Huang et al., 1998). The
initial nuclear accumulations of the PNC component polypy-
rimidine tract-binding protein (PTB) were directly adjacent to
NAPs as would be expected for a compartment that is on the
nucleolar periphery, but the PNC did not show significant over-
lap with NAPs (Fig. S1, e–h).
 
NAPs form at established NORs
 
To examine the relationship between the association of fibril-
larin with NORs and the assembly of NAPs, both structures
were simultaneously examined in living cells. HeLa cells
stably expressing CFP-fibrillarin were transiently transfected
with YFP-SF2/ASF, and dual color four-dimensional imaging
was performed in living mitotic cells (Fig. 5, a–l). The NORs
were visible as distinct CFP-fibrillarin foci in early telophase
(Fig. 5 a, arrow). YFP-SF2/ASF was not yet detectable in
daughter nuclei at this time (Fig. 5 g). Clearly, the NAPs are
the first sites where YFP-SF2/ASF is enriched in daughter nu-
clei (Fig. 5 i), and they appeared a few minutes after CFP-
fibrillarin first accumulated in NORs. We conclude that fi-
brillarin associates with NORs before the accumulation of
YFP-SF2/ASF in NAPs.
 
Ultrastructure of the NAPs
 
To investigate the ultrastructural relationship between the ac-
tive NORs and NAPs, immunoelectron microscopy was per-
formed on telophase HeLa cells. The early telophase state of
the cell in Fig. 6 a is evident by the abundance of SF2/ASF in
cytoplasmic MIGs (Fig. 6 a, arrowheads). Also, although there
are several regions of dense heterochromatin throughout the
nuclei, there is no indication of granular IGCs, confirming
the absence of nuclear speckles at this stage (Fig. 6 a). In the
daughter nuclei, endogenous SF2/ASF was localized in several
electron-dense granular patches around NORs, and it was
clearly excluded from the interior of the NOR (Fig. 6, b and c;
enlarged NAPs from the top and bottom nuclei, respectively).
Furthermore, the nuclear envelope appeared intact in nuclei
where NAPs were observed.
 
Organization of a functional nuclear 
envelope precedes NAP formation
 
SR protein accumulation in NAPs occurs earlier than bulk SR
protein nuclear entry but after NORs are activated. Because
rDNA becomes transcriptionally active during anaphase, we
wanted to be certain that the nuclear membrane is established
before SR proteins associate with NAPs. We performed a func-
tional assay in living cells to assess whether or not the nuclear
Figure 5. NAPs form at established NORs. Dual-color four-dimensional imaging revealed the temporal sequence of nuclear domain establishment (a–l).
Cells stably expressing CFP-fibrillarin (a–f) were transiently transfected with a cDNA construct encoding YFP-SF2/ASF (g–l). CFP-fibrillarin (a, arrow) had
clearly accumulated in NORs for several minutes before YFP-SF2/ASF first accumulated in NAPs (i, arrows). Images are projections of confocal z-stacks
collected every 2 min. Bar, 5 m.
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membrane is competent for import when NAPs first appear
(Fig. 6, d–o). HeLa cells stably expressing YFP-SF2/ASF were
transiently transfected with the importin-
 

 
 binding domain
(IBB) of importin 
 

 
 fused to HcRed. The IBB-HcRed entered
nuclei in late anaphase (Fig. 6 e, arrows), whereas the initial
accumulation of YFP-SF2/ASF in NAPs occurred minutes
later (Fig. 6 m, arrows). This experiment confirmed that the nu-
clear membrane is fully assembled and functional for nuclear
import before the formation of NAPs in daughter nuclei and in-
dicates that YFP-SF2/ASF enters nuclei via active transport.
 
SF2/ASF rapidly exchanges between 
NAPs and the nucleoplasm
 
To determine if SF2/ASF traffics through NAPs, we examined
the exchange of SF2/ASF at NAPs by FRAP (Fig. 7, a–f). A
representative fluorescence recovery curve is shown in Fig. 7 f
for the region bleached in Fig. 7 a (boxed). FRAP analysis of a
typical NAP indicated that SF2/ASF had a half time of fluores-
cence recovery of 
 

 
1.8 s (
 

 
 0.6). The average fluorescence
recovery curve from 14 experiments is shown in Fig. S2
(available at http://www.jcb.org/cgi/content/full/jcb.200404120/
Figure 6. Ultrastructure of NAPs and time-lapse of nuclear envelope assembly. Ultrastructure of the NAPs was determined during early telophase (a–c) by
using immunoelectron microscopy. Electron-dense material was deposited where SF2/ASF antibody was localized around forming nucleoli (a, arrows)
and in MIGs (a, arrowheads). Enlarged images from the top (b) and bottom (c) cells show that SF2/ASF is excluded from the NOR interior. (d–o) Dual
four-dimensional imaging of NAPs and nuclear import in living HeLa cells. A functional nuclear envelope was established as indicated by import of
IBB-HcRed (e, arrows), before YFP-SF2/ASF began to accumulate in NAPs (m, arrows). Images are projections of confocal z-stacks collected every 2 min.
Bars: (a) 1 m; (d–o) 5 m.
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DC1). As we also wanted to know how SR protein transit
through NAPs compared with transit through the nucleoplasm,
half of a nucleus was bleached such that the bleached region in-
cluded a NAP (Fig. S2). Interestingly, the recovery of YFP-
SF2/ASF in the NAPs occurred at the same rate as the YFP-
SF2/ASF in the nucleoplasm, suggesting that diffusion is the
limiting determinant for recovery.
 
Quantitation of YFP-SF2/ASF flux 
through NAPs
 
Next, we wanted to know if all SF2/ASF could potentially tran-
sit through NAPs upon nuclear entry. The amount of YFP-SF2/
ASF in NAPs in living telophase cells was quantified by dual
high-resolution four-dimensional imaging of YFP-SF2/ASF
(Fig. 7, g–v). Hoechst staining allowed imaging of the chroma-
tin for calculation of nuclear volume (Fig. 7, g–k). The amount
of YFP-SF2/ASF in NAPs (Fig. 7 m) was quantified relative to
nucleoplasmic and cytoplasmic pools of YFP-SF2/ASF (Fig.
S3 for procedure and Table S1 for intensity sums, available
at http://www.jcb.org/cgi/content/full/jcb.200404120/DC1). As
expected, the cytoplasmic pool decreased as the nucleoplasmic
pool increased (Fig. 7 v), and the total fluorescence was main-
tained throughout the experiment (Table S1). The average
amount of YFP-SF2/ASF in NAPs in the example shown was
 

 
1.17% (Fig. 7 m; and Fig. 7 v, right y-axis) and it averaged
1.02% (
 

 
 0.146) of the total cellular signal in three independent
experiments. Although there is no difference in recovery time
of SF2/ASF in NAPs versus the nucleoplasm (Table S1), YFP-
SF2/ASF is 2.7 times more concentrated in NAPs than in the
nucleoplasm, further demonstrating the importance of these do-
Figure 7. Dynamics and quantification of
YFP-SF2/ASF in NAPs. FRAP analysis indicates
that turnover of YFP-SF2/ASF at NORs is
rapid. A representative of 14 NAP photo-
bleaching experiments is shown in panels a–f.
Photobleaching of NAPs (a, boxed area) re-
vealed that the average half time of FRAP of
YFP-SF2/ASF in NAPs was 1.8 s ( 0.6; re-
covery curve, f; see also Fig. S3, available
at http://www.jcb.org/cgi/content/full/
jcb.200404120/DC1). High-resolution dual
color four-dimensional imaging data set is
shown in panels g–v. Intensity sums of fluores-
cence of YFP-SF2/ASF in different cellular
compartments during the early stages of
daughter nuclei reformation (g–v) revealed
that 1.17% of YFP-SF2/ASF is found at
NAPs during early telophase in the example
shown (m, NAPs; v, right y-axis). Data shown
in g–v is representative of three experiments.
Bars: (a–e) 2.5 m; (g–u) 5 m.
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mains in the early stages of subnuclear SR protein organization.
Combining the facts that 
 

 
1% of cellular SF2/ASF resides in
NAPs and that 50% of SF2/ASF in NAPs exchanges in 
 

 
2 s al-
lows the estimate that it would require 
 

 
6 min to shuttle all cel-
lular SF2/ASF through NAPs (100%/0.51% 
 
 
 
1.8 s 
 
	 
 
353 s).
As NAPs typically persist for 15–20 min, all SF2/ASF could
feasibly visit NAPs at least once during a normal telophase.
 
NAP integrity is modulated by 
transcriptional activity
 
Because SR proteins are present in NAPs before entry into nu-
clear speckles, we were interested in determining the effect of
NAP formation and maintenance under conditions where RNA
polymerase II transcription was inhibited as cells exited mito-
sis. Interestingly, inhibition of RNA polymerase II transcrip-
tion during telophase, by 
 

 
-amanitin treatment, caused NAPs
to become larger and brighter and to persist longer. Endoge-
nous SF2/ASF accumulation at NAPs was exaggerated under
these conditions (Fig. 8, a–d), suggesting that SR proteins pref-
erentially target NAPs when transcription sites are absent. This
result was confirmed in living cells, as YFP-SF2/ASF accumu-
lation in NAPs continued for at least 2 h (Fig. 8, e–h), during
which time the NAPs increased in size over the first 65 min and
eventually diminished but were not completely absent by 2 h
(Fig. 8 h). This is a dramatically longer association of SF2/ASF
with NAPs, compared with SF2/ASF in untreated cells, in
which NAPs disappear after 
 

 
20 min (Fig. 1 j). Furthermore,
SF2/ASF entry into nuclear speckles was delayed (i.e., speck-
les were just beginning to accumulate SF2/ASF by 2 h) com-
pared with untreated cells in which nuclear speckles ac-
cumulate SF2/ASF immediately (Fig. 1 k). Interestingly,
endogenous SF2/ASF (Fig. S4, a–h, available at http://
www.jcb.org/cgi/content/full/jcb.200404120/DC1) and YFP-
SF2/ASF (Fig. 8 i, arrows) in interphase cells treated with
 

 
-amanitin were redistributed from nuclear speckles to the pe-
ripheral nucleolar region. In the same cells, snRNPs remained
in rounded, enlarged nuclear speckles and were not targeted to
the nucleolar periphery (Fig. 8 j, arrowhead), consistent with
the segregation of different families of splicing factors at telo-
phase. SC35 tagged with RFP also redistributed from nuclear
speckles to the peripheral nucleolar region (Fig. S4, i–p). Iden-
tical results were obtained with other RNA polymerase II in-
hibitors (e.g., actinomycin D and DRB; unpublished data).
These results implicate RNA polymerase II transcription in ap-
propriate subnuclear targeting of SR proteins after mitosis, and
they demonstrate a previously unrecognized role of NAPs in
Figure 8. Inhibition of RNA polymerase II during telophase delays targeting of YFP-SF2/ASF to nuclear speckles. In mitotic cells treated with the specific
RNA polymerase II inhibitor -amanitin, endogenous SF2/ASF (a, arrow) accumulated much more extensively around NORs (labeled with fibrillarin;
b and c, arrow) than in untreated cells (Fig. 4). In living mitotic cells treated with -amanitin (e–h), YFP-SF2/ASF continued to accumulate in NAPs for at
least 2 h (h, arrow indicates NAP remnant), 100 min longer than it persists in NAPs in untreated cells. Even after 2 h, accumulation of SF2/ASF nuclear
speckles was not abundant (h, compare with Fig. 1, j and k). Arrows in a–h indicate NAP position. Confocal images are representative projections from a
typical sequence in which z-stacks were collected every 5 min. Immunofluorescence of interphase cells treated with -amanitin showed that similar to
the localization of SR proteins during telophase, a significant amount of YFP-SF2/ASF was redistributed to the periphery of nucleoli (i, arrows). snRNPs
remained in rounded, enlarged nuclear speckles and were not targeted to the nucleolar periphery (j, arrowhead). Arrows (i–l) indicate nucleolar periphery.
Arrowheads (i–l) indicate rounded-up nuclear speckles. DNA was stained with DAPI (d and l). Bars, 5 m.
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the pathway of SR splicing factor trafficking and biogenesis of
nuclear speckles.
 
Discussion
 
We have characterized a transient nuclear domain (NAPs)
where SR proteins accumulate during a limited temporal win-
dow in telophase. The NAPs form around active NORs after
nuclear envelope assembly, but before the onset of nuclear
speckle formation. The results of this paper are key to building
a time line of nuclear compartment assembly following mito-
sis. They also bring to light the fact that, in general, constitu-
ents of nuclear bodies, including prerRNA processing factors,
components of CBs and PML bodies, and pre-mRNA process-
ing factors, do not immediately localize to and/or assemble
their resident bodies in daughter nuclei. Instead, there is a lag
phase after mitosis as nuclear proteins first enter daughter nu-
clei and accumulate temporarily with proteins of similar func-
tion(s) before nuclear bodies (i.e., nuclear speckles and CBs)
are established in G1. These transient associations of subsets of
proteins may be necessary for modification/maturation or par-
tial assembly of multimolecular subcomplexes before localiza-
tion to nuclear bodies in G1. The subsequent organization of
nuclear compartments such as nuclear speckles would then
provide further modification/maturation and recycling/mainte-
nance of protein complexes during interphase.
We expected that all pre-mRNA processing factors
would simultaneously reassemble into speckles in telophase
daughter cells. Instead, we found a distinct localization of dif-
ferent families of pre-mRNA processing factors in different re-
gions of telophase nuclei. The U2 snRNP protein B
 

 
, snRNAs
(m
 
3
 
G), and the CB resident protein p80 coilin were all found at
polar regions of daughter nuclei. CBs are discrete nuclear com-
partments that can associate with U1, U2, and U3 snRNA gene
loci and histone gene loci (Frey and Matera, 1995; Smith et al.,
1995; Gao et al., 1997; Frey et al., 1999) and have been impli-
cated in snRNP maturation and assembly (Sleeman and La-
mond, 1999; Darzacq et al., 2002) and in snoRNA posttranscrip-
tional modification and targeting to the nucleolus (Narayanan
et al., 1999; Verheggen et al., 2002). CBs do not acquire their
distinctive morphology until late telophase/G1 (Sleeman and
Lamond, 1999; unpublished data). Therefore, the observed lo-
calization of snRNPs and p80 coilin at polar regions of daugh-
ter nuclei may be important for assembling the initial nuclear
populations of snRNPs before CB formation.
During interphase, snRNPs may follow a nonrandom
path as a short pulse of YFP-snRNP protein expression allowed
tracking of the accumulation of snRNPs from the CB to the nu-
cleoli, and then to the speckles (Sleeman and Lamond, 1999).
With the entry of snRNPs into the next compartment, there was
clear depletion of snRNPs from the previous compartment
(Sleeman and Lamond, 1999). Sleeman and Lamond (1999)
concluded that the snRNPs are directly enriched in “speckles”
during telophase without first passing through CBs, suggesting
that snRNPs do not require modification/maturation at CBs
upon entry into daughter nuclei. However, colocalization with
SR proteins was not examined to confirm that these sites of sn-
RNP enrichment are the equivalent of interphase speckles. As
we have found a polar distribution of snRNPs in daughter nu-
clei, what was interpreted as a “speckle” during telophase
(Sleeman and Lamond, 1999) is more likely equivalent to what
we have shown here as polar localization of snRNPs. Further-
more, the accumulation of both snRNPs and coilin in the same
nuclear region is more suggestive of the early stages of CB or-
ganization than of nuclear speckle organization.
The initial localization of SR proteins around NORs in
telophase implicates this region in SR protein modification/
maturation. The fact that 
 

 
-amanitin blocks trafficking of SR
proteins from the perinucleolar region to transcription sites and/
or nuclear speckles during interphase implicates a role for the
nucleolar periphery specifically in SR protein modification/
maturation during interphase as well. Interestingly, telophase
NAPs increased in size and were maintained for a longer period
of time when RNA polymerase II transcription was turned off,
and SR proteins were left without a pre-mRNA target. Transit
through the nucleolar periphery in interphase may be very
rapid, similar to the rapid exchange in NAPs observed in FRAP
experiments during telophase. Thereby, the steady-state level of
SR proteins at the nucleolar periphery may be below the detec-
tion limits or indistinguishable from the nuclear speckle pattern
(e.g., speckles on the periphery of the nucleoli), and could
therefore be observed only upon RNA polymerase II inhibition
when a build up occurs due to the depletion of a downstream
target. A similar scenario was observed for hnRNP proteins
when it was first discovered that they shuttle continuously be-
tween the nucleus and the cytoplasm (Pinol-Roma and Drey-
fuss, 1993). The hnRNP proteins are entirely nuclear when ob-
served by immunofluorescence, and no hnRNP is detectable in
the cytoplasm. However, upon inhibition of RNA polymerase II
transcription, some hnRNP proteins (e.g., A1 and K) accumu-
lated in the cytosol, revealing that these proteins traffic between
the nucleus and cytoplasm during interphase (Pinol-Roma and
Dreyfuss, 1993). Here, we have shown interruption in the traf-
ficking pathway of SR proteins, with preferential targeting to
the nucleolar periphery under conditions where RNA polymer-
ase II is inhibited, suggesting that this region is important
for continuous SR protein modification/maturation/trafficking.
This interpretation is strengthened by similar observations
made for snRNP trafficking during interphase, as snRNPs were
shown to proceed from the cytoplasm to the CBs, and then into
nucleoli before accumulation in nuclear speckles (Sleeman and
Lamond, 1999). Interestingly, SR proteins such as SF2/ASF
have been identified in proteomic analysis of nucleoli (Leung et
al., 2003). Our results support a model in which SR proteins
traffic through the nucleolar periphery in interphase cells, in
contrast to snRNPs, which were not detected at the nucleolar
periphery, and is consistent with what is seen at mitotic exit as
the two families of splicing factors spatially separated in the
daughter nuclei. The initial accumulations of SR proteins in
NAPs during telophase may reflect the beginning of SR protein
modification/maturation/trafficking in the new cell cycle, a
time when global transcriptional activity is more reduced than
during interphase and much less pre-mRNA target is available
for the splicing machinery.
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The state of chromatin condensation and nuclear speckle
integrity are inversely correlated through the cell cycle (Smith
et al., 1985). In our work, we found that SR proteins did not di-
rectly accumulate in nuclear speckles in telophase, but initially
accumulated around NORs, which contain repetitive rDNA and
are the first extensive regions of chromatin that become highly
decondensed and transcribed following mitosis. Human nuclei
contain 10 NORs located on the short arms of acrocentric chro-
mosomes 13, 14, 15, 21, and 22 (Kaplan and O’Connor, 1995),
six of which are associated with transcription factors in HeLa
cells during mitosis and are the sites where rRNA is synthe-
sized and nucleoli form (Roussel et al., 1996). We considered
the possibility that NORs may be the initial targets for SR pro-
teins because they serve some transient function in nucleolar
biogenesis. However, this is unlikely because SF2/ASF is
always found in regions directly surrounding NORs, not coin-
cident with NORs. It is also unlikely that the SR proteins are
involved in splicing pre-mRNAs originating from transcrip-
tionally active genes that flank NORs or from active chromatin
domains in the vicinity of NORs because large regions of het-
erochromatin isolate the rDNA repeats (Sylvester et al., 1986;
Worton et al., 1988). Also, during the temporal window that
NAPs were observed, polyA
 

 
 RNA was absent from nuclei.
Furthermore, our data presented here do not support this possi-
bility because the snRNPs, which are enriched elsewhere in the
telophase nucleus, would also be expected to accumulate on
such transcripts. We also addressed the possibility that SR pro-
teins may be targeted to NAPs because they are directly in-
volved in modulating the condensation state of rDNA. Recent
reports indicated that topoisomerase I is found in fibrillar cen-
ters of nucleoli and NORs (Christensen et al., 2002) and that
SF2/ASF interacts with topoisomerase I to inhibit its DNA re-
laxation activity (Andersen et al., 2002). However, we con-
firmed that GFP-topoisomerase I is found in fibrillar centers,
but does not colocalize with SF2/ASF in NAPs (unpublished
data), suggesting that NAPs are not directly involved in these
processes.
Perhaps SF2/ASF accumulation in NAPs is necessary for
modification of SR proteins required for their targeting to nu-
clear speckles. Phosphorylation by SR protein kinases regulates
the release of SR proteins from nuclear speckles (Colwill et al.,
1996b) as well as their splicing activity (Prasad et al., 1999).
Our earlier studies showed that hyperphosphorylation of SR
proteins in vivo does not simply release SR proteins from
speckles, but leads to complete disassembly of nuclear speckles
(Sacco-Bubulya and Spector, 2002). On the contrary, hypo-
phosphorylation of SR proteins in vivo causes bright foci to
form on the speckle periphery, consistent with inhibition of SR
protein release from speckles (Sacco-Bubulya and Spector,
2002). We concluded that the SR protein–SR protein interac-
tions are the basis for nuclear speckle organization during inter-
phase and would therefore play a critical role in nuclear speckle
assembly in daughter nuclei. NAPs provide the only example
during the cell cycle in which SR proteins are sequestered from
other pre-mRNA processing factors. We have now demon-
strated in this paper that SR proteins in NAPs are hypophos-
phorylated. The sequestration and hypophosphorylated state of
the SR proteins at NAPs would favor RS domain–RS domain
interactions for establishing NAPs. As the recovery time of SR
proteins in NAPs is rapid, a simple mechanism such as this for
the establishment of NAPs is the most logical. The presence of
Clk/STY at NAPs could be a result of the RS repeats found in
the amino terminus of the kinase; however, it also suggests
phosphorylation as a means for SR protein activation for subse-
quent participation in pre-mRNA splicing. Alternatively, the
function of Clk/STY at NAPs could be to release SR proteins
from NAPs, or both activities could result from the same phos-
phorylation event. Although it would potentially be informative
to examine the localization of SR protein deletion mutants and
substitutions with regard to their localization to NAPs during
telophase, this is not possible due to the delayed entry of such
proteins into daughter nuclei (unpublished data).
If SR protein interactions are the basis for nuclear speckle
organization, nuclear speckles could be assembled/disassem-
bled during the cell cycle simply by regulating the level of phos-
phorylation of RS domains. Phosphorylation of different serine
residues within the RS domain may confer different activities or
functions upon SR proteins or interactions with different part-
ners and/or subnuclear compartments. This possibility is also
supported by the finding that 
 
Schizosaccharomyces pombe
 
 con-
tains only two SR proteins and nuclear speckles have not been
observed in these cells (Potashkin et al., 1990), and no SR pro-
teins are encoded in the 
 
Saccharomyces cerevisiae
 
 genome and
once again no speckles have been identified in these cells (for
review see Graveley, 2000). In mammalian cells, it is not clear
how pre-mRNA processing factors are activated to a splicing-
competent state in newly forming nuclei that have not yet as-
sembled nuclear speckles. Our current observations suggest that
regions surrounding NORs are important sites for initially segregat-
ing SR proteins away from other splicing factors, to modify
them or to allow them to interact before association with pre-
mRNA transcripts or nuclear speckles. This finding raises ques-
tions for future study regarding how SR proteins and snRNPs
follow two separate pathways to eventually become targeted to
the same speckle regions within daughter nuclei. It will be im-
portant to determine if SR proteins and snRNPs first meet at
transcription sites before recycling of complexes through nu-
clear speckles. It also raises questions about how different nu-
clear compartments assemble/disassemble and communicate
with each other as nuclear domains are established after mitosis.
 
Materials and methods
 
cDNA constructs
 
PCR was used to generate a restriction site at the stop codon of human
SC35 cDNA for convenient subcloning into pEYFP-N1 (CLONTECH Labo-
ratories, Inc.) or a vector encoding monomeric RFP. SF2/ASF was sub-
cloned from GFP-SF2/ASF vector (Misteli et al., 1997) into pEYFP-C1.
Fibrillarin (provided by S. Huang, Northwestern University Medical School,
Chicago, IL) was subcloned from pEGFP-fibrillarin vector into pECFP. IBB-
Hc-Red was provided by E. Zanin (EMBL, Heidelberg, Germany).
 
Cell culture and transfection
 
Cells were grown in Dulbecco’s MEM (Life Technologies) supplemented
with penicillin-streptomycin and 10% FBS (Hyclone). For transient transfec-
tion of HeLa cells, electroporation (240 V; 950 
 

 
F) was performed on
cells resuspended in 250 
 

 
l of Dulbecco’s MEM and transferred to cu-
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vettes containing 2 
 

 
g of plasmid plus 20 
 

 
g of salmon sperm DNA. Cells
were seeded onto acid-washed coverslips and processed for immunofluo-
rescence localization of proteins 2 d after transfection. Stable HeLa cell
lines expressing CFP-fibrillarin or YFP-SF2/ASF were selected in 1 mg/ml
G-418. 50 
 

 
g/ml 
 

 
-amanitin was added to culture medium for 6 h before
fixation or 30 min before live cell imaging. For immunoblotting, HeLa cells
were subjected to microfractionation (Mendez and Stillman, 2000), and 8
 

 
l of soluble nuclear extract was incubated in a total volume of 10 
 

 
l with
2 U of calf intestinal phosphatase (New England Biolabs, Inc.) for 30 min
at 37
 


 
C. Extract was applied to SDS PAGE followed by immunoblot using
anti-SC35 (SCf11; 1:20) antibody.
 
Immunofluorescence
 
Cells were rinsed in PBS and fixed for 15 min in 2% formaldehyde in PBS,
pH 7.4. Cells were permeabilized in PBS 
 

 
 0.2% Triton X-100 
 

 
 0.5%
goat serum. Nascent transcripts were labeled by adding 2 mM 5-fluoro-
UTP to culture medium. The following primary antibodies were added for
1 h at RT: anti-(hyperphosphorylated)SC35 (1:1,000), SCf11 anti-(hypo-
phosphorylated)SC35 (1:20; provided by J. Stevenin, Institut de Genet-
ique et de Biologie, Moleculaire et Cellulaire, Illkirch, France); anti-B
 

 
(1:200; provided by W. van Venrooij, University of Nijmegen, Nijmegen,
Netherlands), mAb103 anti-SF2/ASF (1:100; provided by A. Krainer,
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY); anti-snRNA
m
 
3
 
G (1:40); ANA-N (fibrillarin, 1:10); anti-UBF (1:100); anti-BrdU
(1:500; Sigma-Aldrich); anti-nucleolin (1:100); anti-PTB (1:200); mouse anti-
coilin 5P10 (1:100; provided by M. Carmo-Fonseca, University of Lisbon,
Lisbon, Portugal); rabbit anti-coilin R228 (1:400; provided by E. Chan,
The Scripps Research Institute, La Jolla, CA); and anti-Clk/STY (1:100; BD
Biosciences). Cells were rinsed in PBS 
 
 0.5% goat serum, and secondary
anti-species–specific antibodies (Jackson ImmunoResearch Laboratories)
were added for 1 h at RT. RNA-FISH was performed as described previ-
ously (Sacco-Bubulya and Spector, 2002) with probes synthesized from
rDNA template (provided by M. Dundr, National Cancer Institute, Be-
thesda, MD) using a nick translation reagent kit (VYSIS) to incorporate
spectrum red-dUTP (VYSIS). Fixed cells were examined using a fluores-
cence microscope (model Axioplan 2i; Carl Zeiss MicroImaging, Inc.)
equipped with Chroma filters (Chroma Technology Corp.), and OpenLab
software (Improvision) was used to collect digital images. Alternatively,
fixed cells were observed on a Deltavision microscope (Applied Precision)
and images were deconvolved using SoftWorx.
Live cell microscopy
HeLa cells stably expressing YFP-SF2/ASF were seeded onto coverslips
and grown for 2 d. The cells were directly imaged in a LabTekII chamber
slide (Lab Tek) or transferred to an FCS2 live-cell chamber (Bioptechs),
which was mounted onto the stage of a microscope (model LSM 510; Carl
Zeiss MicroImaging, Inc.) and maintained at 37
C. For time-lapse obser-
vations of NAPs, Z-stacks (2-m optical sections) were acquired every
minute for 1 h. Timing of appearance/disappearance of NAPs was con-
firmed by monitoring all sections in each stack to rule out shift in focus,
movements of NAPs, or mitotic cell movements. Photobleaching experi-
ments were done using a 63 1.4 NA Plan-Apochromat oil immersion
lens and 50 iterations of the 488-nm laser set at 100% power in the area
of the NAP. Acquisition imaging was done at 1.2% laser power with an
open pinhole and a pixel time of 1.6 s; acquisition bleaching was negli-
gible in all FRAP experiments. The average half time of recovery of YFP-
SF2/ASF in NAPs was calculated based on 14 independent bleaching ex-
periments using the same geometry, laser intensity, and bleaching length.
Fluorescence of NAPs was normalized with the whole nucleus intensity
(Fig. 7 a). To compare recovery in NAPs versus the nucleoplasm, half of
the nucleus was photobleached and fluorescence recovery was measured
in a NAP and in the nucleoplasm at the same distance from the bleach
front. For quantification of SF2/ASF in NAPs, DNA was visualized in liv-
ing cells by adding 10 g/ml of Hoechst 33342 30 min before imaging.
1-m optical sections were acquired through the entire mitotic cell (22–
24 m) every 5 min. Three high-resolution four-dimensional data sets were
averaged for quantification of SF2/ASF in NAPs. For quantitation, images
were preprocessed using an anisotropic diffusion filtering (Gerlich et al.,
2001). Cellular compartments were defined by single thresholds that were
applied to whole four-dimensional data sets (Fig. S3). Two different thresh-
olds were interactively determined in the YFP-SF2/ASF channel to identify
whole cellular regions (lower value) and NAP regions (higher value). An
additional threshold was applied on the Hoechst channel to find nuclear
regions. Cytoplasmic regions were determined by subtracting nuclear and
NAP regions from whole cellular regions. Using these region definitions,
total fluorescence intensity was calculated in the unprocessed YFP channel.
EM
HeLa cells were seeded onto gridded Mat Tek dishes and processed for
immunolocalization of SF2/ASF. Cells were rinsed briefly in PBS, fixed in
2% formaldehyde for 15 min, washed in blocking buffer (PBS 0.5% NGS
0.3 M glycine) permeabilized in PBS 2% saponin 0.5% NGS 0.3M gly-
cine, and washed in blocking buffer. Cells were incubated in anti-SF2/
ASF (1:100) overnight at 4
C, washed in blocking buffer, incubated in
biotinylated secondary antibody for 1 h, washed in buffer, and incubated
in ABC complex (Vector Laboratories) for an additional hour. After wash-
ing, the cells were reacted for 6 min in 0.5 mg/ml DAB (Sigma-Aldrich)
with 0.2 L/ml of hydrogen peroxide, rinsed in buffer, and post-fixed in
1% osmium tetroxide for 1 h. Cells were rinsed in double distilled water,
dehydrated in an ethanol series, and infiltrated with Durcupan ACM resin
(Electron Microscopy Sciences). Electron micrographs were recorded from
80-nm-thick sections at 80 kV with a transmission electron microscope
(model 1200 EX; Jeol Ltd.).
Online supplemental material
Supplemental Videos 1 and 2 show time-lapse of NAPs in HeLa cells. Fig.
S1 shows images from a time-lapse of NAPs in HeLa cells that is presented
in Video 2 and exclusion of PTB and nascent transcripts from NAPs. Fig.
S2 shows FRAP recovery curves for SF2/ASF in NAPs. Fig. S3 illustrates
selection of cellular compartments for quantification of fluorescence inten-
sity. Table S1 shows fluorescence intensity values in different cellular com-
partments. Fig. S4 shows localization of endogenous SF2/ASF and SC35-
RFP around nucleoli after -amanitin treatment of HeLa cells. Online
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200404120/DC1.
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